A lower serum level of middle-molecular-weight adiponectin is a risk factor for endometrial cancer

International Journal of Clinical Oncology

Volumn 19, Issue 4, 2014, Pages 667-673

  Ohbuchi, Yukari ^a   Suzuki, Yasunobu ^a   Hatakeyama, Ikuo ^a   Nakao, Yoshifumi ^b   Fujito, Atsuya ^d   Iwasaka, Tsuyoshi ^c   Isaka, Keiichi ^d  

^a Funabashi Municipal Medical Center   (Japan)

^b SAGA UNIVERSITY   (Japan)

^c Takagi Hospital   (Japan)

^d TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Adiponectin; Adiponectin isoforms; BMI; Endometrial cancer

Indexed keywords

ADIPONECTIN; HIGH MOLECULAR WEIGHT ADIPONECTIN; LOW MOLECULAR WEIGHT ADIPONECTIN; MIDDLE MOLECULAR WEIGHT ADIPONECTIN; UNCLASSIFIED DRUG; ISOPROTEIN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER RISK; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION; JAPANESE (PEOPLE); MOLECULAR WEIGHT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; BLOOD; ENDOMETRIUM TUMOR; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RISK FACTOR; VERY ELDERLY;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR WEIGHT; PROGNOSIS; PROTEIN ISOFORMS; RISK FACTORS;

EID: 84906346346     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-013-0603-0     Document Type: Article

References (39)

1. Cancer Incidence (1975-2001), Center for Cancer Control and Information Services, National Cancer Center, Japan. Available at: http://ganjoho.ncc.go.jp/ professional/statistics/statistics.html
2. Maeda K, Okubo K, Shimomura I et al (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun 221:286-289 (Pubitemid 26136463)
3. Scherer PE, Williams S, Fogliano M et al (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746-26749
4. Hu E, Liang P, Spiegelman BM (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271:10697-10703 (Pubitemid 26145805)
5. Nakano Y, Tobe T, Choi-Miura NH et al (1996) Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem 120:803-812 (Pubitemid 26385421)
6. Kubota N, Terauchi Y, Yamauchi T et al (2002) Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277:25863-25866 (Pubitemid 34967064)
7. Yamauchi T, Kamon J, Waki H et al (2003) Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 278:2461-2468 (Pubitemid 36801322)
8. Okamoto Y, Kihara S, Ouchi N et al (2002) Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106:2767-2770 (Pubitemid 35396973)
9. Weyer C, Funahashi T, Tanaka S et al (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935 (Pubitemid 32472900)
10. Fruebis J, Tsao TS, Javorschi S et al (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 98:2005-2010 (Pubitemid 32165613)
11. Yamauchi T, Kamon J, Waki H et al (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946 (Pubitemid 32756432)
12. Lindsay RS, Funahashi T, Hanson RL et al (2002) Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360:57-58 (Pubitemid 34756495)
13. Kamada Y, Tamura S, Kiso S et al (2003) Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 125:1796-1807 (Pubitemid 37500444)
14. Waki H, Yamauchi T, Kamon J et al (2003) Impaired multimerization of human adiponectin mutants associated with diabetes: molecular structure and multimer formation of adiponectin. J Biol Chem 278:40352-40363 (Pubitemid 37248604)
15. Pajvani UB, Du X, Combs TP et al (2003) Structure-function studies of the adipocyte-secreted hormone Acrp 30/Adiponectin. J Biol Chem 278:9073-9085
16. Tsao TS, Tomas E, Murrey HE et al (2003) Role of disulfide bonds in Acrp 30/adiponectin structure and signaling specificity: different oligomers activate different signal transduction pathways. J Biol Chem 278:50810-50817 (Pubitemid 37548930)
17. Ishikawa M, Kitayama J, Kazama S et al (2005) Plasma adiponectin and gastric cancer. Clin Cancer Res 11:466-472 (Pubitemid 40116868)
18. Mantzoros C, Petridou E, Dessypris N et al (2004) Adiponectin and breast cancer risk. J Clin Endocrinol Metab 89:1102-1107 (Pubitemid 38368397)
19. Wei EK, Giovannucci E, Fuchs CS et al (2005) Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 97:1688-1694 (Pubitemid 41672235)
20. Kelesidis I, Kelesidis T, Mantzoros CS (2006) Adiponectin and cancer: a systematic review. British J Cancer 94:1221-1225
21. Bråkenhielm E, Veitonmäki N, Cao R et al (2004) Adiponectin-induced antiangiogenesis and antitumor activity involve caspasemediated endothelial cell apoptosis. Proc Natl Acad Sci USA 101:2476-2481 (Pubitemid 38269336)
22. Petridou E, Mantzoros C, Dessypris N et al (2003) Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab 88:993-997 (Pubitemid 36337745)
23. Dal Maso L, Augustin LS, Karalis A et al (2004) Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab 89:1160-1163 (Pubitemid 38368405)
24. Soliman PT, Wu D, Tortoleno-Luna G et al (2006) Association between adiponectin, insulin resistance, and endometrial cancer. Cancer 106:2376-2381 (Pubitemid 43787661)
25. Inoue T, Kotooka N, Morooka T et al (2007) High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease. Am J Cardiol 100:569-574 (Pubitemid 47223129)
26. Torigoe M, Matsui H, Ogawa Y et al (2007) Impact of the high-molecular-weight form of adiponectin on endothelial function in healthy young men. Clin Endocrinol (Oxf) 67:276-281 (Pubitemid 47076306)
27. Kobayashi H, Ouchi N, Kihara S et al (2004) Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 94:27-31
28. Tsuchida A, Yamauchi T, Takekawa S et al (2005) Peroxisome proliferator-activated receptor (PPAR) α activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARα, PPARγ and their combination. Diabetes 54:3358-3370 (Pubitemid 43334324)
29. Hara K, Horikoshi M, Yamauchi T et al (2006) Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 29:1357-1362 (Pubitemid 44125935)
30. Wulster-Radcliffe MC, Ajuwon KM, Wang J et al (2004) Adiponectin differentially regulates cytokines in porcine macrophages. Biochem Biophys Res Commun 316:924-929 (Pubitemid 38368041)
31. Yokota T, Oritani K, Takahashi I et al (2000) Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96:1723-1732 (Pubitemid 30661055)
32. Wolf AM, Wolf D, Rumpold H et al (2004) Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 323:630-635 (Pubitemid 39221142)
33. Ouchi N, Kihara S, Funahashi T et al (2003) Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107:671-674 (Pubitemid 36222590)
34. Kubota N, Terauchi Y, Yamauchi T et al (2002) Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277:25863-25866 (Pubitemid 34967064)
35. Ishikawa M, Kitayama J, Yamauchi T et al (2007) Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2. Cancer Sci 98:1120-1127 (Pubitemid 46865400)
36. Yamauchi T, Kamon J, Minokoshi Y et al (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288-1295 (Pubitemid 35373562)
37. Shand B, Elder P, Scott R et al (2006) Biovariability of plasma adiponectin. Clin Chem Lab Med 44:1264-1268 (Pubitemid 44580810)
38. Otto C, Otto B, Göke B et al (2006) Increase in adiponectin levels during pioglitazone therapy in relation to glucose control, insulin resistance as well as ghrelin and resistin levels. J Endocrinol Invest 29:231-236
39. Lely AT, Krikken JA, Bakker SJ et al (2007) Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men. J Clin Endocrinol Metab 92:1821-1826 (Pubitemid 46997195)